News

Proteomics International Laboratories (ASX:PIQ) signs distribution deal for diabetic kidney disease – The Market Herald

The two year distribution and licencing agreement was signed with Italian distributor Medical Horizons SRL and will see PIQ’s test launch exclusively in Italy.

Today’s announcement is significant as it marks the first time Proteomics has distributed the easy-to-use, high volume immunoassay version of the PromarkerD test, which opens up significant new markets.

Article: Proteomics International Laboratories (ASX:PIQ) signs distribution deal for diabetic kidney disease

Subscribe
  • This field is for validation purposes and should be left unchanged.